Replimune Group, Inc. (REPL)
9.82
-0.48
(-4.66%)
USD |
NASDAQ |
Dec 10, 16:00
9.60
-0.22
(-2.24%)
After-Hours: 05:55
Replimune Group EPS Diluted (Quarterly): -0.9041 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rapt Therapeutics, Inc. | -0.652 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| CorMedix, Inc. | 1.259 |
| Verastem, Inc. | -1.347 |
| Anavex Life Sciences Corp. | -0.1144 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -83.10M |
| Total Expenses (Quarterly) | 83.10M |
| Enterprise Value | 522.99M |
| Earnings Yield | -36.74% |
| Normalized Earnings Yield | -36.74 |